Two Major Pharma M&A Deals Yield Big-Firm Bonanza

, The Am Law Daily

   | 0 Comments

Weil, Wachtell, Shearman, Simpson, Latham and Davis Polk all got the year's second quarter off to a strong start by grabbing roles on one of two big pharmaceutical deals announced Monday: Irish specialty drugmaker Mallinckrodt's $5.6 billion cash-and-stock purchase of California's Questcor Pharmaceuticals and India's Sun Pharmaceutical Industries' $3.2 billion buy of struggling rival Ranbaxy Laboratories.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202650106651

Thank you!

This article's comments will be reviewed.